SEARCH

SEARCH BY CITATION

References

  • 1
    Cohnheim J. Thrombose und Embolie. Vorlesung über allgemeine Pathologie. Berlin, Hirschwald, 1877: 134.
  • 2
    Nedeltchev K, Mattle HP. Contrast-enhanced transcranial Doppler ultrasound for diagnosis of patent foramen ovale. Front Neurol Neurosci 2006; 21:20615.
  • 3
    Doufekias E, Segal AZ, Kizer JR. Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol 2008; 51:104959.
  • 4
    Meissner I, Khandheria BK, Heit JA et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006; 47:4405.
  • 5
    Schwerzmann M, Nedeltchev K, Meier B. Patent foramen ovale closure: a new therapy for migraine. Catheter Cardiovasc Interv 2007; 69:27784.
  • 6
    Weber F, Goriup A. Prevalence of right-to-left shunts in active fighter pilots. Aviat Space Environ Med 2007; 78:1356.
  • 7
    Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59:1720.
  • 8
    Seib G. Incidence of the patent foramen cordis in adult American whites and American Negroes. Am J Anat 1935; 55:51125.
  • 9
    Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007; 49:797802.
  • 10
    Ward R, Jones D, Haponik EF. Paradoxical embolism: unrecognized problem. Chest 1995; 108:54958.
  • 11
    Lechat P, Mas JL, Lascault G et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318:114852.
  • 12
    Webster MW, Chancellor AM, Smith HJ et al. Patent foramen ovale in young stroke patients. Lancet 1988; 2:112.
  • 13
    Chen WJ, Lin SL, Cheng JJ, Lien WP. The frequency of patent foramen ovale in patients with ischemic stroke: a transesophageal echocardiographic study. J Formos Med Assoc 1991; 90:7448.
  • 14
    De Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992; 69:131620.
  • 15
    Cabanes L, Mas JL, Cohen A et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55-years of age. A study using transesophageal echocardiography. Stroke 1993; 24:186573.
  • 16
    Job FP, Ringelstein EB, Grafen Y et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994; 74:3814.
  • 17
    Jones EF, Calafiore P, Donnan GA, Tonkin AM. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994; 74:5969.
  • 18
    Zahn R, Lehmkuhl S, Lotter R, Zander M, Senges J. Cardiac sources of cerebral ischemic events with special regard to a patent foramen ovale. Herz Kreislauf 1995; 27:27984.
  • 19
    Del Sette M, Angeli S, Leandri M et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case–control study. Cerebrovasc Dis 1998; 8:32730.
  • 20
    Petty GW, Khandheria BK, Meissner I et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc 2006; 81:6028.
  • 21
    Jeanrenaud X, Bogousslavsky J, Payot M, Regli F, Kappenberger L. Patent foramen ovale and cerebral infarct in young patients. Schweiz Med Wochenschr 1990; 120:8239.
  • 22
    Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992; 70:66872.
  • 23
    Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117:4615.
  • 24
    Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993; 24:10204.
  • 25
    Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993; 24:314.
  • 26
    Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994; 25:5826.
  • 27
    Albers GW, Comess KA, DeRook FA et al. Transesophageal echocardiographic findings in stroke subtypes. Stroke 1994; 25:238.
  • 28
    Klötzsch C, Janssen G, Berlit P. Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology 1994; 44:16036.
  • 29
    Schminke U, Ries S, Daffertshofer M, Staedt U, Hennerici M. Patent foramen ovale: a potential source of cerebral embolism? Cerebrovasc Dis 1995; 5:1338.
  • 30
    Yeung M, Khan KA, Shuaib A. Transcranial Doppler ultrasonography in the detection of venous to arterial shunting in acute stroke and transient ischaemic attacks. J Neurol Neurosurg Psychiatry 1996; 61:4459.
  • 31
    Petty GW, Khandheria BK, Chu CP, Sicks JD, Whisnant JP. Patent foramen ovale in patients with cerebral infarction. A transesophageal echocardiographic study. Arch Neurol 1997; 54:81922.
  • 32
    Roijer A, Lindgren A, Algotsson L, Norrving B, Olsson B, Eskilsson J. Cardiac changes in stroke patients and controls evaluated with transoesophageal echocardiography. Scand Cardiovasc J 1997; 31:32937.
  • 33
    Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischemic stroke: a case–control study. Stroke 1998; 29:13228.
  • 34
    Steiner MM, Di Tullio MR, Rundek T et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998; 29:9448.
  • 35
    Kanda N, Yasaka M, Otsubo R, Nagatsuka K, Minematsu K, Yamaguchi T. Right-to-left shunt and atrial septal aneurysm in stroke patients: a contrast transesophageal echocardiographic study. Rinsho Shinkeigaku 1998; 38:2138.
  • 36
    Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357:22628.
  • 37
    Force M, Massabuau P, Larrue V. Prevalence of atrial septal abnormalities in older patients with cryptogenic ischemic stroke or transient ischemic attack. Clin Neurol Neurosurg 2008; 110:77983.
  • 38
    Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case–control studies. Neurology 2000; 55:11729.
  • 39
    Chaikof EL, Campbell BE SRB. Paradoxical embolism and acute arterial occlusion: rare or unsuspected? J Vasc Surg 1994; 20:37784.
  • 40
    Inoue T, Tadehara F, Hinoi T et al. Paradoxical peripheral embolism coincident with acute pulmonary thromboembolism. Intern Med 2005; 44:2435.
  • 41
    Dethy S, Manto M, Kentos A et al. PET findings in a brain abscess associated with a silent atrial septal defect. Clin Neurol Neurosurg 1995; 97:34953.
  • 42
    Moon RE, Camporesi EM, Kisslo JA. Patent foramen ovale and decompression sickness in divers. Lancet 1989; 1:5134.
  • 43
    Rigatelli G, Giordan M, Braggion G et al. Incidence of extracerebral paradoxical embolism in patients with intracardiac shunts. Cardiovasc Revasc Med 2007; 8:24850.
  • 44
    Silver MT, Lieberman EH, Thibault GE. Refractory hypoxemia in inferior myocardial infarction from right-to-left shunting through a patent foramen ovale: a case report and review of the literature. Clin Cardiol 1994; 17:62730.
  • 45
    Cheng TO. Platypnea–orthodeoxia syndrome: etiology, differential diagnosis, and management. Cathet Cardiovasc Interv 1999; 47:646.
  • 46
    Beelke M, Angeli S, Del Sette M et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003; 4:21923.
  • 47
    Allemann Y, Hutter D, Lipp E et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA 2006; 296:29548.
  • 48
    Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999; 52:16225.
  • 49
    Alzamora MT, Sorribes M, Heras A. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study. BMC Neurol 2008; 8:5.
  • 50
    Kraywinkel K, Jauss M, Diener HC, Weimar C. Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evidence. Nervenarzt 2005; 76:93542.
  • 51
    Hansen A, Kuecherer H. Caught in the act: entrapped embolus through a patent foramen ovale. Eur J Echocardiogr 2008; 9:6923.
  • 52
    Thanigaraj S, Zajarias A, Valika A, Lasala J, Perez JE. Caught in the act: serial, real time images of a thrombus traversing from the right to left atrium across a patent foramen ovale. Eur J Echocardiogr 2006; 7:17981.
  • 53
    Belkin RN, Hurwitz BJ, Kisslo J. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke 1987; 18:85662.
  • 54
    Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995; 26:10308.
  • 55
    Jones HRJ, Caplan LR, Come PC, Swinton NWJ, Breslin DJ. Cerebral emboli of paradoxical origin. Ann Neurol 1983; 13:3149.
  • 56
    Adams HPJ. Cardiac disease and stroke: will history repeat itself? Mayo Clin Proc 2006; 81:597601.
  • 57
    Bonati LH, Kessel-Schaefer A, Linka AZ et al. Diffusion-weighted imaging in stroke attributable to patent foramen ovale: significance of concomitant atrial septum aneurysm. Stroke 2006; 37:20304.
  • 58
    Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr 2004; 17:2313.
  • 59
    De Castro S, Cartoni D, Fiorelli M et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000; 31:240713.
  • 60
    Telman G, Yalonetsky S, Kouperberg E, Sprecher E, Lorber A, Yarnitsky D. Size of PFO and amount of microembolic signals in patients with ischaemic stroke or TIA. Eur J Neurol 2008; 15:96972.
  • 61
    Fox ER, Picard MH, Chow CM, Levine RA, Schwamm L, Kerr AJ. Interatrial septal mobility predicts larger shunts across patent foramen ovales: an analysis with transmitral Doppler scanning. Am Heart J 2003; 145:7306.
  • 62
    Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005; 112:106372.
  • 63
    Schuchlenz HW, Saurer G, Weihs W. Patent foramen ovale, atrial septal aneurysm, and recurrent stroke. N Engl J Med 2002; 346:13312.
  • 64
    Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi MG. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007; 38:20703.
  • 65
    Pezzini A, Del Zotto E, Magoni M et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003; 34:2833.
  • 66
    Belvis R, Santamaria A, Marti-Fabregas J et al. Patent foramen ovale and prothrombotic markers in young stroke patients. Blood Coagul Fibrinolysis 2007; 18:53742.
  • 67
    Florez JC, Ay H, Van Cott EM, Buonanno FS. Patent foramen ovale and hypercoagulability as combined risk factors for stroke. J Stroke Cerebrovasc Dis 2003; 12:1148.
  • 68
    Cramer SC, Rordorf G, Maki JH et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004; 35:4650.
  • 69
    Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370:17739.
  • 70
    Berthet K, Lavergne T, Cohen A et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000; 31:398403.
  • 71
    Djaiani G, Phillips-Bute B, Podgoreanu M et al. The association of patent foramen ovale and atrial fibrillation after coronary artery bypass graft surgery. Anesth Analg 2004; 98:5859.
  • 72
    Meier B. Patent foramen ovale, guilty but only as a gang member and for a lesser crime. J Am Coll Cardiol 2006; 47:4468.
  • 73
    Schrale RG, Mitchell AR, Ormerod OJ. Patent foramen ovale and the risk of cryptogenic stroke. J Am Coll Cardiol 2006; 48:19134.
  • 74
    Messe SR, Silverman IE, Kizer JR et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62:104250.
  • 75
    Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105:262531.
  • 76
    Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996; 46:13015.
  • 77
    Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345:17406.
  • 78
    Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006; 113:e40949.
  • 79
    Nedeltchev K, Arnold M, Wahl A et al. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 2002; 72:34750.
  • 80
    Dearani JA, Ugurlu BS, Danielson GK et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100:II1715.
  • 81
    Devuyst G, Bogousslavsky J, Ruchat P et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996; 47:11626.
  • 82
    Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997; 28:237681.
  • 83
    Sievert H, Fischer E, Heinisch C, Majunke N, Roemer A, Wunderlich N. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience. Circulation 2007; 116:17016.
  • 84
    Walpoth NB, Habermacher K, Moarof I et al. Device-less patent foramen ovale closure by radiofrequency thermal energy. Swiss Med Wkly 2008; 138:10813.
  • 85
    Ruiz CE, Kipshidze N, Chiam PT, Gogorishvili I. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure. Catheter Cardiovasc Interv 2008; 71:9216.
  • 86
    Mills NL, King TD. Nonoperative closure of left-to-right shunts. J Thorac Cardiovasc Surg 1976; 72:3718.
  • 87
    Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992; 86:19028.
  • 88
    Hung J, Landzberg MJ, Jenkins KJ et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000; 35:13116.
  • 89
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder. Am J Cardiol 2008; 101:148792.
  • 90
    Wahl A, Meier B, Haxel B et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001; 57:13302.
  • 91
    Windecker S, Wahl A, Chatterjee T et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000; 101:8938.
  • 92
    Windecker S, Wahl A, Nedeltchev K et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44:7508.
  • 93
    Wahl A, Kunz M, Moschovitis A et al. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 2008; 94:33641.
  • 94
    Wohrle J. Closure of patent foramen ovale after cryptogenic stroke. Lancet 2006; 368:3502.
  • 95
    Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand W, Kleinman CS. PFO closure complications from the AGA registry. Catheter Cardiovasc Interv 2008; 72:749.
  • 96
    Shishehbor MH, Christofferson RD, Tuzcu EM, Kapadia SR. Long-term results after PFO closure. Heart 2008; 94:100.
  • 97
    Sigler M, Jux C. Biocompatibility of septal defect closure devices. Heart 2007; 93:4449.
  • 98
    Bayard YL, Ostermayer SH, Hein R et al. Percutaneous devices for stroke prevention. Cardiovasc Revasc Med 2007; 8:21625.
  • 99
    Taaffe M, Fischer E, Baranowski A et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 2008; 101:13538.
  • 100
    Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005; 101:7782.
  • 101
    Wahl A, Krumsdorf U, Meier B et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005; 45:37780.
  • 102
    Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002; 288:32133.
  • 103
    Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37:577617.
  • 104
    European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25:457507.
  • 105
    Brainin M, Barnes M, Baron JC et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004. Eur J Neurol 2004; 11:57781.